Efficacy and Safety of Immunomodulator as an Adjunct Therapy in New Pulmonary Tuberculosis(Category I) Patients.
This study has been completed.
Ministry of Science and Technology, India
Information provided by (Responsible Party):
SK Sharma, All India Institute of Medical Sciences, New Delhi
First received: June 20, 2006
Last updated: April 25, 2013
Last verified: April 2013
No Study Results Posted on ClinicalTrials.gov for this Study
|Study Status:||This study has been completed.|
|Study Completion Date:||March 2012|
|Primary Completion Date:||October 2011 (Final data collection date for primary outcome measure)|